[Asia Economy Reporter Park Soyeon] Shinpung Pharmaceutical is showing strong performance.
As of 10:02 AM on the 30th, Shinpung Pharmaceutical is trading at 72,600 KRW on the KOSPI market, up 6,200 KRW (9.34%) from the previous trading day.
On the 27th, Shinpung Pharmaceutical announced that it received approval from the Ministry of Food and Drug Safety for the Phase 3 clinical trial plan of 'Piramex,' a malaria treatment drug being developed as a COVID-19 treatment.
Shinpung Pharmaceutical has a market capitalization of 3.8626 trillion KRW, ranking 88th on the KOSPI. The number of listed shares is 52,984,990.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
